Abstract
The United Arab Emirates (UAE) is one of the fastest growing economies with consequent increase in non-communicable diseases including cancer. The number of reported cases and mortality have been increasing in the UAE over the years, despite screening and early detection efforts which appear to be far from target coverage of the intended population. In this work, we highlight key elements of a proposed national cancer control plan for the UAE. The plan is still a work in progress and has not yet been officially adopted. A comprehensive and effective control plan requires accurate data, a reliable cancer registry, and periodic monitoring and evaluation. The UAE cancer control plan is being prepared in line with the WHO and EMRO framework, with defined objectives and goals. The objectives are to combat cancer, reduce incidence, control mortality, and improve outcomes and quality of life for cancer patients. There is also a focus on improving public health education, prevention, early detection, prompt diagnosis, treatment facilitation, continuity of care, performance evaluation, training of workforce, and research.
Highlights
Cancer is a major health problem globally, and the second leading cause of death in the world, with a mortality rate of 8.8 million people in 2015, accounting for approximately 1 out of 6 deaths [1]
In 2011 [11,22,23], the World Health Organization (WHO) proclaimed the crucial demand to create a baseline for monitoring trends and to assess the progress of countries to contest the global epidemic of cancer in confronting this scourge
A cancer registry is the key instrument for any cancer control plan
Summary
Citation: Al-Shamsi, H.O.; Abyad, A.M.; Rafii, S. A Proposal for a National Cancer Control Plan for the UAE: 2022–2026. Clin. Pract. 2022, 12, 118–132. https://doi.org/10.3390/ clinpract12010016 Received: 8 December 2021 Accepted: 14 February 2022 Published: 17 February 2022 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
